Having demonstrated that EPO potentially targets not only CFU-E cells but also lung cancer cells, it remained to be addressed if the signaling upon EPO stimulation is identical between the different cell types or if there is a therapeutic window to specifically target lung cancer cells. Here, EPO is linked to lung carcinoma.